Whilst we can't meet in person in 2020, we've taken the conversation digitally @ the 1st Digital Clinical Biomarkers & World CDx (29 September – 01 October, 2020) - view more information here.

Our Industry Leading Expert Speakers

Beth Tréhu

Chief Medical Officer

Jounce Therapeutics

Ekta Patel

Head, Pre-Clinical & Translational Research

Mustang Bio

Darren Hodgson

Global Project Leader & Head of Strategy, Translational Medicine

AstraZeneca

Cecilia Schott

Head, Precision Medicine Strategy, Oncology Business Unit

Novartis

Darrell Borger

Associate Director, Translational Sciences, ODDU

Takeda

Antje Hoering

President & CEO

Cancer Research And Biostatistics

Elizabeth Somers

Diagnostic Pathway Lead, AD Franchise

Eisai

Ellie Corigliano

Global Director, Medical Affairs, Biomarkers & Diagnostics, Thoracic Cancer

Merck & Co.

Elizabeth O’Day

Founder & CEO

Olaris Therapeutics

Hans Bitter

Vice President, Data Sciences

Bluebird Bio

Gregory Preston

Director, Bioanalytical & Biomarker Development

Axial Biotherapeutics

Hakan Sakul

VP & Head, Diagnostics

Pfizer

Jason Hipp

Senior Director, Head of Pathology Data Science & Innovation, Translational Medicine

AstraZeneca

Irene Bacalocostantis

Senior Manager, Regulatory Affairs

Regeneron

Jason Bradt

Head, Rare Disease North America Medical Affairs & Director, Medical Affairs Operations

Ipsen

Jennifer Hamilton

Executive Director & Head, Precision Medicine

Regeneron

Jayanthi Menon

Senior Manager, Regulatory Affairs

Regeneron

Jeffrey Emch

Vice President, Global Commercial Diagnostics Strategy, Oncology

GSK

Julie Ramage

Director, Precision Medicine Quality Initiatives & Partnerships

AstraZeneca

Jennifer Herring

Executive Director, Head, Clincial Scientists, Cellular Therapy, Global Development

Bristol Myers Squibb

Julie Engel

Senior Director, Molecular Diagnostics

Cyteir Therapeutics

Majid Ghoddusi

Senior Director, Clinical Biomarkers

Poseida Therapeutics

Kristina McGuire

Senior Director

Regeneron

Lauren Silvis

Senior Vice President, External Affairs

Tempus

Maria Orr

Head, Precision Medicine, Biopharmaceuticals

AstraZeneca

Michael Kiebish

Cheif Precision Medicine Officer & Vice President, Systems Medicine

BERG Health

Mark Roberts

Senior Director, Diagnostics Development

Covance

Ornit Chiba-Falek

Professor, Chief, Division of Translational Brain Sciences, Department of Neurology & Center for Genomic & Computational Biology

Duke University Medical Center

Pashtoon Kasi

Assistant Professor, College of Medicine & Oncology

University of Iowa

Omar Perez

Head, Diagnostics, Experimental Medicine Unit

GSK

Paul Kassner

Senior Vice President, Quantitative & Computational Biology

RAPT Therapeutics

Robert Loberg

Executive Director, Clinical Biomarkers & Diagnostics

Amgen

Patrice Hugo

Chief Scientific Officer

Q2 Solutions

Robert Pomponio

Global Scientific Advisor, Biomarkers & Clinical Bioanalysis TMED

Sanofi

Roman Yelensky

Chief Technology Officer

Gritstone Oncology

Robert McCormack

Independent

Sarah Paul

Senior Associate

Genentech

Russell Garlick

Chief Scientific Officer

LGC Clinical Diagnostics

Ryan Keeling

Chief Innovation Officer

Diaceutics

Sid Mathur

Regulatory Affairs Director, Companion Diagnostics

Merck & Co.

Smitha Sivaraman

Senior Director, US Medical Affairs

Incyte

T. Scott Reid

Executive Director, Strategic Alliances & CDx

NeoGenomics

Tooba Cheema

Director, Translational Medicine & Biomarkers

Oncorus

Vasiliki Pelekanou

Clinical Translational Medical Lead, Oncology

Sanofi

Xiaolei Xu

Director, Global Regulatory Affairs, Companion Diagnostics

Agilent Technologies